Cutler Group LP Verastem, Inc. Put Options Transaction History

Cutler Group LP

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2021 Oct 26, 2021	SELL	$2.54 - $4.07 $5,588 - $8,954	-2,200 Reduced 66.67%	1,100 $1,000
Q2 2021 Jul 19, 2021	BUY	$2.57 - $4.85 $8,224 - $15,519	3,200 Added 3200.0%	3,300 $1,000
Q1 2019 May 10, 2019	SELL	$2.79 - $4.09 $5,301 - $7,771	-1,900 Reduced 95.0%	100 $0
Q4 2018 Feb 05, 2019	SELL	$3.23 - $7.01 $16,473 - $35,751	-5,100 Reduced 71.83%	2,000 $3,000
Q3 2018 Nov 07, 2018	BUY	$6.86 - $9.97 $43,218 - $62,811	6,300 Added 787.5%	7,100 $5,000
Q2 2018 Aug 10, 2018	BUY	$2.88 - $8.67 $2,304 - $6,936	800 New	800 $0

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.25B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.